338 related articles for article (PubMed ID: 8615637)
1. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells.
Bogush T; Robert J
Anticancer Res; 1996; 16(1):365-8. PubMed ID: 8615637
[TBL] [Abstract][Full Text] [Related]
2. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
Mankhetkorn S; Dubru F; Hesschenbrouck J; Fiallo M; Garnier-Suillerot A
Mol Pharmacol; 1996 Mar; 49(3):532-9. PubMed ID: 8643093
[TBL] [Abstract][Full Text] [Related]
3. [Intracellular accumulation, retention, and distribution of anthracyclines in a multidrug-resistant variant K562r].
Hu X; Chen WY
Zhongguo Yao Li Xue Bao; 1994 May; 15(3):275-9. PubMed ID: 7976387
[TBL] [Abstract][Full Text] [Related]
4. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
Mankhetkorn S; Garnier-Suillerot A
Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
[TBL] [Abstract][Full Text] [Related]
5. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
Tapiero H; Nguyen-Ba G; Lampidis TJ
Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms.
Urasaki Y; Ueda T; Yoshida A; Fukushima T; Takeuchi N; Tsuruo T; Nakamura T
Anticancer Res; 1996; 16(2):709-14. PubMed ID: 8687117
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a K562 multidrug-resistant cell line.
Yanovich S; Hall RE; Gewirtz DA
Cancer Res; 1989 Aug; 49(16):4499-503. PubMed ID: 2568171
[TBL] [Abstract][Full Text] [Related]
8. [Anthracycline transport in sensitive and resistant leukemia cells].
Erttmann R; Erb N; Forcadell de Dios P; Neurath C; Looft G; Landbeck G
Klin Padiatr; 1989; 201(1):40-5. PubMed ID: 2704176
[TBL] [Abstract][Full Text] [Related]
9. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
Watanabe M; Komeshima N; Naito M; Isoe T; Otake N; Tsuruo T
Cancer Res; 1991 Jan; 51(1):157-61. PubMed ID: 1988080
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
[TBL] [Abstract][Full Text] [Related]
11. Comparison of idarubicin and daunorubicin and their main metabolites regarding intracellular uptake and effect on sensitive and multidrug-resistant HL60 cells.
Tidefelt U; Prenkert M; Paul C
Cancer Chemother Pharmacol; 1996; 38(5):476-80. PubMed ID: 8765443
[TBL] [Abstract][Full Text] [Related]
12. Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance.
Hindenburg AA; Baker MA; Gleyzer E; Stewart VJ; Case N; Taub RN
Cancer Res; 1987 Mar; 47(5):1421-5. PubMed ID: 3469017
[TBL] [Abstract][Full Text] [Related]
13. Action mechanism of idarubicin (4-demethoxydaunorubicin) as compared with daunorubicin in leukemic cells.
Fukushima T; Ueda T; Uchida M; Nakamura T
Int J Hematol; 1993 Apr; 57(2):121-30. PubMed ID: 8494991
[TBL] [Abstract][Full Text] [Related]
14. Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells.
Côme MG; Skladanowski A; Larsen AK; Laurent G
Br J Cancer; 1999 Mar; 79(7-8):1090-7. PubMed ID: 10098741
[TBL] [Abstract][Full Text] [Related]
15. Comparison of drug accumulation in P-glycoprotein-expressing and MRP-expressing human leukaemia cells.
Davey MW; Hargrave RM; Davey RA
Leuk Res; 1996 Aug; 20(8):657-64. PubMed ID: 8913319
[TBL] [Abstract][Full Text] [Related]
16. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
17. Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell death.
Gieseler F; Nüssler V; Brieden T; Kunze J; Valsamas S
Int J Clin Pharmacol Ther; 1998 Jan; 36(1):25-8. PubMed ID: 9476145
[TBL] [Abstract][Full Text] [Related]
18. Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833.
Michieli M; Damiani D; Michelutti A; Candoni A; Masolini P; Scaggiante B; Quadrifoglio F; Baccarani M
Haematologica; 1994; 79(6):500-7. PubMed ID: 7896208
[TBL] [Abstract][Full Text] [Related]
19. Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells.
Merlin JL; Marchal S; Ramacci C; Dieterlen A; Schultz G; Lucas C; Poullain MG; Berlion M
Cytometry; 1995 Aug; 20(4):315-23. PubMed ID: 7587719
[TBL] [Abstract][Full Text] [Related]
20. [Role of cell pharmacokinetics in the modulation of modalities in the administration of anthracyclines].
Tapiéro H; Boule D; Trincal G; Fourcade A
Pathol Biol (Paris); 1987 Jan; 35(1):20-6. PubMed ID: 3550608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
